{"id":"W4415940076","doi":"10.1016/j.annonc.2025.08.3151","title":"2537eTiP PSMACare trial-in-progress: a phase II trial of [177Lu]Lu-PSMA-617 with or without ARPI in patients with PSMA-positive non-metastatic castration-resistant prostate cancer","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal; Montreal General Hospital","funders":"Novartis","keywords":"Prostate cancer; Glutamate carboxypeptidase II; Androgen receptor; Androgen deprivation therapy; Radioligand; Androgen; Phases of clinical research; Prostate-specific antigen","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001501395,0.001937083,0.002522582,0.0004624837,0.0004729836,0.002068665,0.00131137,0.001540199,0.009043035],"category_scores_gemma":[0.0008598276,0.0006399186,0.001930665,0.0005376409,0.001342894,0.001176013,0.0004702866,0.005818862,0.003402326],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001089421,"about_ca_system_score_gemma":0.002074522,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002031574,"about_ca_topic_score_gemma":0.004610879,"domain_scores_codex":[0.9996198,0.0001565686,0.00001386714,0.00005933472,0.00003524889,0.0001151737],"domain_scores_gemma":[0.9995342,0.00007465552,0.0000639401,0.00004106863,0.00002525825,0.0002607437],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7562687,0.03082093,0.003502962,0.001576748,0.003117562,0.0004398406,0.0004129311,0.004630391,0.02652973,0.002095028,0.02108565,0.1495195],"study_design_scores_gemma":[0.8184546,0.1658723,0.004301949,0.00006116369,0.0008218479,0.000317995,0.00009493939,0.00140076,0.001777352,0.0006249851,0.006222143,0.00005000245],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.9658254,0.006740438,0.00134669,0.003063615,0.0007452497,0.003721082,0.004500414,0.0006380751,0.01341892],"genre_scores_gemma":[0.9588303,0.005743015,0.003226975,0.003512425,0.0005789278,0.003024451,0.01122143,0.0002300842,0.0136324],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.009043035,"threshold_uncertainty_score":0.03025198,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0617472521708245,"score_gpt":0.4518964900308142,"score_spread":0.3901492378599897,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}